Australia News
-
Australia develops breakthrough blood test for COVID-19 detection
Australia | News | 0 Comment | 21 Jul, 2020
The research team, led by Bioresource Processing Institute of Australia (BioPRIA) and Monash University’...Read more
-
Australian Government Injects $13.6m on Innovative Cancer Treatments trials
Australia | News | 1 Comment | 17 Jul, 2020
In early June 2020, Australia’s Department of Health offered $13.6 million to support 10 clinical trials rese...Read more
-
India discusses bilateral health co-operation with Australia
Australia | News | 0 Comment | 16 Jul, 2020
Dr. Harsh Vardhan, Union Minister for Health and Family Welfare, Government of India had a digital interaction with his ...Read more
-
Clinuvel launches second afamelanotide formulation
Australia | News | 0 Comment | 15 Jul, 2020
Australia based CLINUVEL Pharmaceuticals, has announced PRÉNUMBRA®, the Company’s second afamelanotide ...Read more
-
Luina Bio, XING to bring in fast SARS-CoV-2 diagnostic kit
Australia | News | 0 Comment | 14 Jul, 2020
Australia based Luina Bio is pleased to announce they have been selected to partner with XING Technologies (Brisbane) to...Read more
-
Carromex unveils leads for rapid drug analysis and discovery
Australia | News | 0 Comment | 13 Jul, 2020
Carromex, a mathematical research-based innovation company based in Australia, unveiled a new cloud-based pharmaceu...Read more
-
Avance Clinical Wins Frost & Sullivan “2020 Asia-Pacific CRO Market Leadership Award”
Australia | News | 0 Comment | 09 Jul, 2020
The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacifi...Read more
-
CSL Behring evaluates monoclonal Ab for respiratory distress
Australia | News | 0 Comment | 08 Jul, 2020
Australia based CSL Limited's part, CSL Behring has announced that the first patient has been enrolled in its ...Read more
-
Affinity discovers potent SARS-CoV-2 antibodies
Australia | News | 0 Comment | 03 Jul, 2020
Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for canc...Read more
-
Australia starts new projects to deal with drug resistance
Australia | News | 0 Comment | 02 Jul, 2020
Australia’s commitment to support the health and wellbeing of the Pacific Island neighbours remains steadfast, wit...Read more
-
Australia invests $19M in AI health research projects
Australia | News | 0 Comment | 01 Jul, 2020
The Australian Government is investing $19 million in transformative medical research projects using game-changing appli...Read more
-
Alterity meets US FDA for ATH434 pathway to treat Multiple System Atrophy
Australia | News | 0 Comment | 30 Jun, 2020
Alterity Therapeutics announced that it has received guidance from the US Food and Drug Administration (FDA) in relation...Read more
-
Australia to study first interventional neuromodulation platform
Australia | News | 0 Comment | 29 Jun, 2020
US based Synchron Inc., a neurovascular bioelectronic medicine company, has announced that the University of Melbou...Read more
-
Neoteryx gets blood collection device registered in Australia
Australia | News | 0 Comment | 30 Jun, 2020
The Mitra® microsampling device from US company Neoteryx has been registered as a Class I in vitro diagnostic (IVD) ...Read more
-
Australia pitches $12M more for CVD research
Australia | News | 0 Comment | 26 Jun, 2020
The Australian government, together with the National Heart Foundation, is announcing a further $12 million for research...Read more
-
Australia invests over $5.7M in traumatic brain injury research
Australia | News | 0 Comment | 25 Jun, 2020
The Australian Government is investing over $5.7 million to further develop traumatic brain injury research, aimed at im...Read more
-
Cardiovascular disease (CVD) impact on Asia-Pacific markets
Australia | Analysis | 2 Comment | 23 Jun, 2020
HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...Read more
-
EIU launches APAC Economist Intelligence Unit report for heart ailments
Australia | News | 0 Comment | 23 Jun, 2020
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...Read more
